Literature DB >> 7238274

Circulating trypsin-like immunoreactivity in chronic pancreatitis.

A Andriulli, G Masoero, M Felder, I Vantini, M Petrillo, G Cavallini, G Bianchi Porro, G Dobrilla, G Verme.   

Abstract

The present study has been designed to work out the factors regulating the fasting serum levels of trypsin-like immunoreactivity in chronic pancreatitis. One hundred patients with chronic pancreatitis have been included and studied during a painless phase of the disease. No relationships have been observed between serum trypsin-like immunoreactivity and the presence of pancreatic calcifications. Serum immunoreactive trypsin levels showed a gradual decline parallel to the progressive impairment of bicarbonate and enzyme (trypsin and chymotrypsin) outputs in duodenal aspirates during pancreatic secretory studies. Therefore, serum trypsin-like immunoreactivity levels are thought to reflect the functional capacity of the exocrine pancreas. Reduced levels of trypsin-like immunoreactivity were detected in almost all patients with diabetes and steatorrhea. However, the finding of low levels also in a minority of chronic pancreatitis patients with normal endoscopic retrograde cholangiopancreatography or pancreatic secretory tests points to other factors which, in addition to the atrophy of the pancreatic parenchyma, may influence the circulating levels of trypsin-like immunoreactivity in chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238274     DOI: 10.1007/bf01308103

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  [DETERMINATION OF CHYMOTRYPSIN AND TRYPSIN IN DUODENAL JUICE].

Authors:  C FIGARELLA; J TAULIER; H SARLES
Journal:  Bull Soc Chim Biol (Paris)       Date:  1965

2.  The preparation and properties of two new chromogenic substrates of trypsin.

Authors:  B F ERLANGER; N KOKOWSKY; W COHEN
Journal:  Arch Biochem Biophys       Date:  1961-11       Impact factor: 4.013

3.  Relationship between alcoholism and pancreatic insufficiency.

Authors:  E P DiMagno; J R Malagelada; V L Go
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

4.  The role of caerulein in tests of exocrine pancreatic function.

Authors:  G Cavallini; R Mirachian; G Angelini; I Vantini; B Vaona; P Bovo; F Gelpi; A Ederle; G Dobrilla; L A Scuro
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

5.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

6.  Serum immunoreactive trypsin concentration after a Lundh meal. Its value in the diagnosis of pancreatic disease.

Authors:  G Lake-Bakaar; S McKavanagh; M Redshaw; T Wood; J A Summerfield; E Elias
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

7.  [Radio-immunologic measurement of trypsin in chronic pancreatitis. Preliminary results].

Authors:  C Gobelet; J Bambule; J P Felber; P Magnenat; R Séchaud
Journal:  Schweiz Med Wochenschr       Date:  1978-12-02

8.  Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma.

Authors:  T E Adrian; H S Besterman; C N Mallinson; A Pera; M R Redshaw; T P Wood; S R Bloom
Journal:  Clin Chim Acta       Date:  1979-10-01       Impact factor: 3.786

9.  Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin.

Authors:  E Elias; M Redshaw; T Wood
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

10.  Radioimmunoassay of trypsin-like substance in human serum.

Authors:  R Malvano; M Marchisio; A Massaglia; P A Giacosa; M Zannino; A Andriulli; A Burlina
Journal:  Scand J Gastroenterol Suppl       Date:  1980
  10 in total
  15 in total

1.  Variations in time of serum pancreatic enzyme levels in chronic pancreatitis and clinical course of the disease.

Authors:  L Benini; S Caliari; B Vaona; G Brocco; R Micciolo; P Rizzotti; A Fioretta; G Castellani; G Cavallini; L A Scuro
Journal:  Int J Pancreatol       Date:  1991-05

2.  Elastase-1 vs trypsin, lipase and amylase serum levels in pancreatic diseases.

Authors:  L Benini; P Rizzotti; B Vaona; C Sembenini; G Brocco; R Micciolo; G Chiarioni; P Pederzoli; I Vantini; G Cavallini
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

3.  Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.

Authors:  P Malfertheiner; M Büchler; A Stanescu; W Uhl; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1987-06

Review 4.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 4. Tests involving the measurement of pancreatic enzymes in body fluid.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

5.  Serum trypsinogen.

Authors:  A Andriulli; G Masoero
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

6.  Predictive value of a low serum trypsinogen.

Authors:  W M Steinberg; S S Goldstein; N D Davis; K K Anderson; J M Shamma'a
Journal:  Dig Dis Sci       Date:  1985-06       Impact factor: 3.199

7.  Serum trypsin-like immunoreactivity and steatorrhea.

Authors:  J Møller-Petersen; J O Pedersen
Journal:  Dig Dis Sci       Date:  1985-08       Impact factor: 3.199

8.  Serum trypsinogen in diagnosis of chronic pancreatitis.

Authors:  W M Steinberg; K K Anderson
Journal:  Dig Dis Sci       Date:  1984-11       Impact factor: 3.199

9.  Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases.

Authors:  G Masoero; A Andriulli; A Bianco; V Benitti; M Marchetto; M De La Pierre
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

10.  Serum elastase 1 in chronic pancreatic disease.

Authors:  G Del Favero; C Fabris; M Plebani; A Panucci; A Piccoli; L Perobelli; A Burlina; R Naccarato
Journal:  Klin Wochenschr       Date:  1985-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.